Theravance Biopharma Inc Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

Theravance Biopharma Inc free cash flow generation index. Theravance Biopharma Inc (TBPH) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of $208.04 Million represents 1% of operating cash flow ($208.07 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$208.04 Million
USD

Operating Cash Flow

$208.07 Million
USD

Capital Expenditures

$34.00K
USD

Free Cash Flow Generation Index of Theravance Biopharma Inc (2025–2025)

Free cash flow generation index of Theravance Biopharma Inc from 2025 to 2025. Historical FCF Generation Index trend for Theravance Biopharma Inc across 1 annual periods. See how financially flexible is Theravance Biopharma Inc to measure the company's free cash flow as a share of total liabilities.

Theravance Biopharma Inc Free Cash Flow Generation Index by Year (2025–2025)

Theravance Biopharma Inc free cash flow generation index by year from 2025 to 2025. Year-by-year Free Cash Flow Generation Index for Theravance Biopharma Inc. For the full cash flow conversion analysis, see cash flow conversion of Theravance Biopharma Inc.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2025 1.00x $238.50 Million $238.54 Million $42.00K —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).